Search Results

Should you get both vaccinations? Yes, says an infectious disease doctor with the U.S. National Foundation for Infectious Diseases.

https://www.cslbehring.com/vita/2021/protecting-yourself-from-covid-19-and-influenza

One of Greater Chicago’s largest news stations, WGN9, interviews Dr. Gregg Sylvester, Head of Medical Affairs for Seqirus.

https://www.cslbehring.com/vita/2021/whats-next-for-the-flu

CSL Behring presents the World of Promise podcast series, focused on biotechnology and its promise to transform the lives of people and patients around the world living with serious and rare diseases.

https://www.cslbehring.com/our-company/csl-behring-podcasts

CSL Behring is a leading global biotech company driven by its promise to save and improve lives. We manufacture remedies for serious and rare diseases.

https://www.cslbehring.com/

See what Beverly Taylor, a leader at one of the world’s largest flu vaccine providers, Seqirus, said about the upcoming flu season – and how the World Health Organization and a global team of biotech experts are planning for it.

https://www.cslbehring.com/vita/2021/flu-will-return-make-no-doubt-about-it

Early research shows the potential of sa-mRNA “as the next generation of influenza vaccine technology,” says Roberta Duncan, who is leading the mRNA program at global flu vaccine leader Seqirus.

https://www.cslbehring.com/vita/2022/stat-news-highlights-sa-mrna

Get tips for overcoming “trypanophobia” so health care visits go smoothly.

https://www.cslbehring.com/vita/2021/fear-of-needles-is-a-sticking-point

The accomplished scientist offers this advice: “Like those early days, we need to play hard to our competitive advantages.”

https://www.cslbehring.com/vita/2021/andrew-cuthbertson-reflects-on-25-years-with-csl

Even prior to the Omicron variant, U.S. experts urged four COVID-19 shots for this group after research found the vaccines produced a weaker immune response in those with primary immunodeficiency.

https://www.cslbehring.com/vita/2021/three-shots-and-a-booster-for-immune-compromised-patients

A leader with Seqirus, a major flu vaccine producer, talks about the twin threats of influenza and COVID-19.

https://www.cslbehring.com/vita/2021/listen-protecting-public-health-during-the-pandemic